# Contact Legit Wolverine: Editorial Inquiries on the BPC-157 TB-500 Digest

> Contact Legit Wolverine with editorial corrections or citation questions about the BPC-157 TB-500 research digest. An editorial project only — no medical advice, no products, no orders.

For corrections, citation questions, and editorial feedback on the published record — not for medical guidance or product requests.

## Editorial inquiries only

Use the form below to reach the editorial desk about the BPC-157 TB-500 digest — a flagged citation, a study we missed, a correction to the regulatory summary, or a question about how we read a finding. We read every message in that spirit, and corrections to the published record are the messages we most want to receive.

A few things this desk cannot do, stated plainly so no one is misled. We do not provide medical advice, dosing guidance, or treatment recommendations. We are not a clinic and do not evaluate patients or issue prescriptions. We do not sell, supply, source, or price the blend or either constituent, and we cannot direct anyone to a pharmacy, clinic, or vendor. Questions about whether a compounded preparation is appropriate for a person belong with an appropriately licensed prescriber, not with an editorial project — that boundary is the whole point of the site, not a disclaimer bolted onto it.

## Send a message

The form collects a name, an email address, and a message, and routes it to the editorial desk. No data is sold or shared, and the site stores nothing beyond what is needed to reply. For regulatory questions, the [Wolverine legal status and 503A access](/legal-status) page already lays out the FDA record and cites it; for the science, the references register is the fastest route to source.

---

A glazed-tile reading panel on the BPC-157 TB-500 blend — each tendon, wound, and angiogenesis study set in its own tile beside the FDA 503A and access record, with no clinic behind the panel and nothing here dispensed.